- Clinical Analysis
- Indian Pharmaceutical Company
- June 21, 2021
- 0 Comments
Indian Pharmaceutical Company conducts Clinical Analysis for the Supplement to battle against Post COVID-19 difficulties
ImmunoSEB + ProbioSEB CSC3 for post-resolution of mild to moderate COVID-19 patients Mumbai, Maharashtra [India], June 21: According to recent stats, 2.77 crores of COVID-19 sufferers were recovered from…